CRIS Current Research Information System

COLANGELI, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.108
AS - Asia 1.639
EU - Europa 1.181
AF - Africa 119
SA - Sud America 84
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.076
VN - Vietnam 476
SG - Singapore 453
CN - Cina 382
GB - Regno Unito 242
SE - Svezia 218
IT - Italia 177
DE - Germania 149
HK - Hong Kong 137
FR - Francia 91
IN - India 78
RU - Federazione Russa 64
BR - Brasile 60
IE - Irlanda 55
TG - Togo 51
UA - Ucraina 44
NL - Olanda 28
ZA - Sudafrica 27
FI - Finlandia 26
JO - Giordania 26
BG - Bulgaria 24
EE - Estonia 21
CI - Costa d'Avorio 18
JP - Giappone 16
CA - Canada 12
MX - Messico 12
TH - Thailandia 11
KR - Corea 10
PH - Filippine 10
NG - Nigeria 8
AR - Argentina 7
BD - Bangladesh 7
ID - Indonesia 7
PL - Polonia 7
TW - Taiwan 7
AT - Austria 6
BE - Belgio 6
CH - Svizzera 6
EC - Ecuador 6
SC - Seychelles 4
AO - Angola 3
CO - Colombia 3
CZ - Repubblica Ceca 3
ES - Italia 3
EU - Europa 3
GR - Grecia 3
PE - Perù 3
SA - Arabia Saudita 3
VE - Venezuela 3
CL - Cile 2
CY - Cipro 2
IQ - Iraq 2
LT - Lituania 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
RS - Serbia 2
TR - Turchia 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GH - Ghana 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
MS - Montserrat 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 5.135
Salva come PNG Salva come JPEG
Città #
Singapore 320
Ashburn 273
Southend 210
Fairfield 183
Chandler 162
San Jose 133
Santa Clara 127
Hong Kong 125
Woodbridge 104
Seattle 101
Hanoi 96
Ho Chi Minh City 93
Houston 90
Wilmington 69
Princeton 63
Cambridge 58
Beijing 56
Dublin 55
Dong Ket 52
Bologna 51
Lomé 51
Ann Arbor 47
Boardman 42
Lauterbourg 30
Nanjing 30
Los Angeles 28
Amman 26
Florence 26
Westminster 26
Berlin 24
Sofia 24
Padova 20
New York 19
Abidjan 18
Jacksonville 18
Jinan 15
Guangzhou 14
Hefei 14
Saint Petersburg 14
Buffalo 13
Da Nang 13
Hebei 13
Helsinki 13
Redondo Beach 13
San Diego 13
Tokyo 13
Turin 13
Changsha 12
Dearborn 12
Haiphong 12
Milan 12
Redmond 12
Nuremberg 11
Rome 11
Chicago 10
Frankfurt am Main 10
Turku 10
Dallas 9
Des Moines 9
Olalla 9
Shenyang 9
Abeokuta 8
The Dalles 8
Thái Nguyên 8
Zhengzhou 8
Council Bluffs 7
Nanchang 7
Ningbo 7
Shanghai 7
Tianjin 7
Bremen 6
Brooklyn 6
Brussels 6
Phoenix 6
Shenzhen 6
Shijiazhuang 6
Bern 5
Bühl 5
Chennai 5
Düsseldorf 5
Falls Church 5
Hangzhou 5
Jiaxing 5
Johannesburg 5
Lanzhou 5
Montreal 5
Munich 5
Taizhou 5
Warsaw 5
Yubileyny 5
Atlanta 4
Bangkok 4
Bến Tre 4
Hải Dương 4
Ninh Bình 4
Orem 4
Quận Bình Thạnh 4
São Paulo 4
Xi'an 4
Amsterdam 3
Totale 3.371
Salva come PNG Salva come JPEG
Nome #
Significant Decrease in Plasma Levels of D-Dimer, Interleukin-8, and Interleukin-12 After a 12-Month Treatment with Rosuvastatin in HIV-Infected Patients Under Antiretroviral Therapy 207
Calcaneal quantitative ultrasound (QUS) and dual X-ray absorptiometry (DXA) bone analysis in adult HIV-positive patients. 200
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 191
Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection. 184
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 183
COVID-19 in patients with HIV-1 infection: a single-centre experience in northern Italy 183
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 182
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 181
HIV-1 early and late diagnosis in the Emilia Romagna Region (Italy): A three year study 181
Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study. 171
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 170
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection. 169
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 168
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines. 168
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. 167
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 166
Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease. 165
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 164
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. 163
Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients 159
Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients. 153
Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy 150
Prevalence of transmitted drug resistance mutations among newly diagnosed HIV-1-infected patients in a large teaching hospital of the Northern Italy 145
Rosuvastatin and atorvastatin preserve renal function in HIV-1-infected patients with chronic kidney disease and hyperlipidaemia 143
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up 140
Raltegravir use prospectically assessed in a major HIV outpatient clinic in Italy: sample population, virological-immunological activity, and tolerability profile 137
Integration among hospital pharmacists and infectious diseases physicians in the outpatient management of HIV infection 124
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir 123
COVID-19 Outcomes in Patients With Uncontrolled HIV-1 Infection. 114
null 113
Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients 106
Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir 94
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain. 70
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience. 50
Efficacy and Safety of Dolutegravir/Lamivudine in Antiretroviral Therapy-Naive People Living With HIV-1 and With High-Level Viremia. 43
Totale 5.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021135 0 0 0 0 0 0 0 0 0 0 15 120
2021/2022649 54 27 35 79 66 26 12 29 21 114 108 78
2022/2023694 51 102 23 94 44 44 11 62 148 19 67 29
2023/2024211 14 31 9 33 10 52 8 21 7 11 9 6
2024/2025724 33 70 57 69 173 35 29 17 5 45 20 171
2025/20261.630 166 108 118 108 190 88 202 76 429 143 2 0
Totale 5.227